In the News

For media inquiries, please contact Susan Bernat – 216.312.4369

10/06/2020

Is telemedicine over- or underhyped?

At the Cleveland Clinic 2020 Medical Innovation Summit, a panel of health system IT executives gathered to discuss the big issues in digital innovation today.

The discussion, moderated by CNBC reporter Chrissy Farr, included Boston-based Mass General Brigham Chief Digital Health Officer Alistair, Erskine, MD; Cleveland Clinic CIO Matt Kull; Winston-Salem, N.C.-based Novant Health Chief Digital and Technology Officer Angela Yochem; and Aurora, Colo.-based UCHealth Chief Innovation Officer Richard Zane, MD. While all panelists agreed that telehealth would be essential in the future, each organization was at a different stage of telehealth roll-out when the pandemic began and has different goals now.


10/05/2020

Coronavirus response, top innovations of 2020 highlight Tuesday’s Cleveland Clinic Medical Innovation Summit

The coronavirus pandemic and health care’s response to it, along with the unveiling of the annual Top 10 Medical Innovations list, are highlights of the Cleveland Clinic Medical Innovation Summit, which will be held Tuesday.


09/29/2020

Spotlight on Collaboration and Digital Innovation atClevelandClinicMedical Innovation Summit

The annual Cleveland Clinic Medical Innovation Summit, which will be held on October 6, features elements that are reflective of what's happening in the greater healthcare landscape: it's virtual; it's collaborative, featuring leaders of other healthcare systems for the first time ever; and there's a focus on the value of digital technology. Registration is free to convene a broad community from around the world to focus on how to continue the transformation of healthcare delivery that was spawned by a global pandemic.


07/28/2020

Anixa Biosciences Breast Cancer Vaccine Technology Nearing FDA Submission

 Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that its prophylactic breast cancer vaccine is making progress towards clinical trials. 


07/01/2020

Microbrush® Introduces New Nasopharyngeal Test Swabs

Microbrush, a leading US-based global manufacturer and supplier of flocked applicators, has launched a nasopharyngeal test swab to meet the growing demand for COVID-19 testing requirements.


06/30/2020

Third Frontier awards $2.4 million to Northeast Ohio universities and companies

The Ohio Third Frontier Commission has awarded $2.4 million to two Northeast Ohio universities and eight companies to help them advance new technologies into the marketplace. The funds were part of $5.34 million the state program awarded to universities and businesses across the state from its Technology Validation and Start-up Fund (TVSF).


02/20/2020

Long-term Changes in Gut Metabolite Predict CHD Risk

New longitudinal data underscore the role of the gut microbial metabolite trimethylamine N-oxide (TMAO) as a predictor of coronary heart disease (CHD) but also the potential for diet to modify its deleterious effects.


02/17/2020

Cleveland hospitals ‘get to the heart’ of new cardiac health innovations

Cleveland Clinic has developed a state of the art central monitoring unit and novel algorithm for monitoring.


01/10/2020

FDA Approves 3D-printed Airway Stents Developed by Cleveland Clinic Doctor

The U.S. Food and Drug Administration (FDA) has cleared patient-specific airway stents developed by Cleveland Clinic physician Tom Gildea, M.D.


01/09/2020

FDA clears patient-specific airway stents developed by Cleveland Clinic physician

The U.S. Food and Drug Administration (FDA) has cleared patient-specific airway stents developed by Cleveland Clinic physician Tom Gildea, M.D.


   <  1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10  >   

Get In Touch With Us